Quicksilver Scientific

Free Shipping on Orders over $300 (Excludes , , )
Quicksilver Scientific Logo
Main Menu
Main Menu
0
0
Subtotal: 0.00

No products in the cart.

D3K2 References

  1. Wilson LR et al. Vitamin D deficiency as a public health issue: using vitamin D 2 or vitamin D 3 in future fortification strategies. Proceedings of the Nutrition Society. 2017 Aug;76(3):392-9. View Abstract
  2. Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Reviews in Endocrine and Metabolic Disorders. 2017 Jun 1;18(2):153-65. View Abstract
  3. Parva NR et al.Prevalence of vitamin D deficiency and associated risk factors in the US population (2011-2012). Cureus. 2018 Jun 5;10(6):e2741. View Abstract
  4. Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. The American journal of clinical nutrition. 2008 Aug 1;88(2):491S-9S. View Abstract
  5. Melamed ML et al. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008 Aug 11;168(15):1629-37. View Abstract
  6. Tripkovic L et al Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr. 2012;95(6):1357–1364. View Full Paper
  7. Cranney A et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess . 2007 Aug;(158):1–235. View Abstract 
  8. White JH. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun. 2008 Sep;76(9):3837-43. View Full Paper
  9. Prietl B et al. Vitamin D and immune function. Nutrients. 2013 Jul 5;5(7):2502–21. View Abstract
  10. Vanherwegen A-S et al. Regulation of immune function by vitamin D and its uses in immunity. Endocrinol Metab Clin North Am. 2017 Dec;46(4):1061–94. View Abstract
  11. Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006 Dec 20;296(23):2832–8. View Absract
  12. Calvo MS, Whiting SJ, Barton CN. Vitamin D intake: a global perspective of current status. J Nutr. 2005;135(2):310-316. [Article]
  13. Zhang R, Naughton DP. Vitamin D in health and disease: current perspectives. Nutr J. 2010;9:65. [Article]
  14. Zdrenghea MT, et al. Vitamin D modulation of innate immune responses to respiratory viral infections. Rev Med Virol [Internet]. 2017 Jan;27(1). View Abstract
  15. Xiao L, et al. Vitamin D supplementation for the prevention of childhood acute respiratory infections: a systematic review of randomised controlled trials. Br J Nutr. 2015 Aug 27:1-9. View Abstract
  16. Martineau AR et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017 Feb 15;356:i6583. View Absract
  17. Yildiz I, Unuvar E, Zeybek U, et al. The role of vitamin D in children with recurrent tonsillopharyngitis.  Ital J Pediatr. 2012 Jun 8;38:25.  View Full Paper
  18. Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009 Feb 23;169(4):384-90. View Full Paper
  19. Quraishi SA, Bittner EA, Christopher KB, Camargo CA Jr. Vitamin D status and community-acquired pneumonia: results from the third National Health and Nutrition Examination Survey. PLoS One. 2013 Nov 15;8(11):e81120. View Full Paper
  20. Anglin RE, Samaan Z, Walter SD, McDonald SD. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry. 2013 Feb;202:100-7. View Full Paper
  21. Anglin RES et al. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry. 2013 Feb;202:100–7. [Article]
  22. Shaffer JA et al. Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials. Psychosom Med. 2014 Apr;76(3):190–6. View Abstract
  23. Penckofer S et al. Vitamin D Supplementation Improves Mood in Women with Type 2 Diabetes. J Diabetes Res. 2017 Sep 7;2017:8232863. View Abstract
  24. Gloth FM 3rd, Alam W, Hollis B. Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging. 1999;3(1):5-7. View Abstract
  25. Landel V et al. Vitamin D, cognition and Alzheimer’s Disease: the therapeutic benefit is in the D-Tails. J. Alzheimers Dis. 2016;53(2):419–444. View Full Paper
  26. Goodwill AM. A systematic review and meta-analysis of the effect of low vitamin D on cognition. J Am Geriatr Soc. 2017 Oct;65(10):2161-2168. View Abstract
  27. Morello M. Vitamin D improves neurogenesis and cognition in a mouse model of Alzheimer’s disease. Mol Neurobiol. 2018 Aug;55(8):6463-6479. View Full Paper
  28. Gangwar AK et al. Role of Vitamin-D in the prevention and treatment of Alzheimer’s disease. Indian J Physiol Pharmacol. 2015 Jan;59(1):94–9. View Abstract
  29. Yin Yet al. Nutrient biomarkers and vascular risk factors in subtypes of mild cognitive impairment: a cross-sectional study. J Nutr Health Aging. 2015 Jan;19(1):39–47. View Abstract
  30. Wood JM et al. Vitamin D and neurocognitive disorder due to Alzheimer’s disease: A review of the literature. Ann Clin Psychiatry. 2015 Aug;27(3):206–12. View Abstract
  31. Mheid IA et al. Vitamin D and cardiovascular disease. State-of-the-Art-Review. Journal of the American College of Cardiology 2017 (70):1: 89-100 View Abstract
  32. Rai V et al. Role of vitamin D in cardiovascular diseases.Endocrinol Metab Clin North Am. 2017 Dec;46(4):1039-1059 View Abstract
  33. Brinkley DM et al. Vitamin D and heart failure. Curr Heart Fail Rep. 2017 Oct;14(5):410-420. View Abstract
  34. Khan A et al. Nanomedical studies of the restoration of nitric oxide/peroxynitrite balance in dysfunctional endothelium by 1,25-dihydroxy vitamin D3 – clinical implications for cardiovascular diseases.Int J Nanomedicine. 2018 Jan 19;13:455-466. View Abstract
  35. Mathyssen C et al. Vitamin D supplementation in respiratory diseases: evidence from randomized controlled trials. Pol Arch Intern Med. 2017 Nov 30;127(11):775–84. View Abstract
  36. Burkes RM et al. Associations among 25-Hydroxyvitamin D levels, lung function, and exacerbation outcomes in COPD: An analysis of the SPIROMICS cohort. Chest. 2020 Jan 17. View Abstract
  37. Sluyter JD et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients [Internet]. 2017 Dec 13;9(12). View Abstract
  38. Bügel S. Vitamin K and bone health in adult humans. Vitam Horm. 2008;78:393-416. View Abstract
  39. Iwamoto I, Kosha S, Noguchi S-i. A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women a comparative study with vitamin D3 and estrogen-progestin therapy. Maturitas. 1999;31(2):161-164. [Article]
  40. Onodera K, Takahashi A, Sakurada S et al. Effects of phenytoin and/or vitamin K2 (menatetrenone) on bone mineral density in the tibiae of growing rats. Life Sciences. 2002;70(13):1533-1542. [Article]
  41. Spector AA et al. Membrane lipid composition and cellular function. J Lipid Res. 1985 Sep;26(9):1015-35 View Full Paper
  42. Porter CJ. Drug delivery to the lymphatic system. Crit Rev Ther Drug Carrier Syst. 1997;14(4):333-93 View Full Paper
  43. Ahn H et al. Liposomal delivery systems for intestinal lymphatic drug transport. Biomater Res. 2016 Nov 23;20:36 View Full Paper
  44. Alyautdin R et al. Nanoscale drug delivery systems and the blood brain barrier. Int J Nanomedicine. 2014 Feb 7;9:795-811 View Full Paper
0
    0
    Your Cart
    You're 50.00 away from free shipping.
    Your cart is empty
    Continue Shopping
      Calculate Shipping
      Apply Coupon